首页 > 最新文献

Communicable diseases intelligence (2018)最新文献

英文 中文
Measles secondary vaccine failure in a childcare setting: an outbreak report. 儿童保育机构麻疹二次疫苗接种失败:疫情报告。
Q3 Medicine Pub Date : 2024-11-21 DOI: 10.33321/cdi.2024.48.61
Donna Barnekow, Debbie Neucom, Wendy Tout, Dustylee Williams, Michael J Thomas, Sanmarié Schlebusch, Alyssa Pyke, Madisen S Roser, Isaac Tranter, Amalie Dyda, Colleen L Lau, Nicolas R Smoll

Abstract: The Sunshine Coast Public Health Unit (SCPHU) identified a measles case in a childcare educator (CE) with secondary vaccine failure (SVF). The CE had been exposed to a confirmed measles case in a hospital emergency department and later developed symptoms including fever, cough, malaise, and a rash. Diagnostic tests confirmed measles virus infection. Sunshine Coast Public Health Unit (SCPHU) implemented control measures including contact tracing, vaccination, post-exposure prophylaxis, and quarantine for susceptible contacts. Out of 372 identified contacts, 72 were identified as susceptible, all of whom were infants and children. Despite the CE having close contact to all susceptible infants and children, no onward transmission occurred. This suggests that SVF cases pose a lower risk of spreading measles compared to immunologically naïve individuals. This report highlights the importance of prioritising immunologically naïve cases in outbreak responses.

摘要:阳光海岸公共卫生股(SCPHU)发现一名儿童保育员(CE)感染了麻疹病例,并伴有继发性疫苗接种失败(SVF)。该儿童保育员曾在医院急诊科接触过一例麻疹确诊病例,随后出现发烧、咳嗽、不适和皮疹等症状。诊断检测证实他感染了麻疹病毒。阳光海岸公共卫生股(SCPHU)采取了控制措施,包括追踪接触者、接种疫苗、接触后预防以及对易感接触者进行隔离。在已确认的 372 名接触者中,有 72 人被确认为易感人群,他们都是婴幼儿。尽管行政长官与所有易感婴幼儿都有密切接触,但并未发生继续传播。这表明,与免疫力低下的人相比,SVF 病例传播麻疹的风险较低。这份报告强调了在应对疫情时优先考虑免疫力低下病例的重要性。
{"title":"Measles secondary vaccine failure in a childcare setting: an outbreak report.","authors":"Donna Barnekow, Debbie Neucom, Wendy Tout, Dustylee Williams, Michael J Thomas, Sanmarié Schlebusch, Alyssa Pyke, Madisen S Roser, Isaac Tranter, Amalie Dyda, Colleen L Lau, Nicolas R Smoll","doi":"10.33321/cdi.2024.48.61","DOIUrl":"https://doi.org/10.33321/cdi.2024.48.61","url":null,"abstract":"<p><strong>Abstract: </strong>The Sunshine Coast Public Health Unit (SCPHU) identified a measles case in a childcare educator (CE) with secondary vaccine failure (SVF). The CE had been exposed to a confirmed measles case in a hospital emergency department and later developed symptoms including fever, cough, malaise, and a rash. Diagnostic tests confirmed measles virus infection. Sunshine Coast Public Health Unit (SCPHU) implemented control measures including contact tracing, vaccination, post-exposure prophylaxis, and quarantine for susceptible contacts. Out of 372 identified contacts, 72 were identified as susceptible, all of whom were infants and children. Despite the CE having close contact to all susceptible infants and children, no onward transmission occurred. This suggests that SVF cases pose a lower risk of spreading measles compared to immunologically naïve individuals. This report highlights the importance of prioritising immunologically naïve cases in outbreak responses.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2024. 澳大利亚脑膜炎球菌监测:报告期为 2024 年 4 月 1 日至 6 月 30 日。
Q3 Medicine Pub Date : 2024-11-21 DOI: 10.33321/cdi.2024.48.54
Monica M Lahra, Sonya Natasha Hutabarat, Tiffany R Hogan

Abstract: The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and molecular based techniques. Data contained in quarterly reports are restricted to a description of case numbers of IMD by jurisdiction and serogroup, where known and expanded in 2024 to include antimicrobial resistance data for ceftriaxone, penicillin, ciprofloxacin and rifampicin. A full analysis of laboratory confirmations of IMD in each calendar year is contained in the AMSP annual reports.

摘要:澳大利亚脑膜炎球菌监测计划(AMSP)的参考实验室利用培养和分子技术报告经实验室检测确诊的侵袭性脑膜炎球菌病(IMD)病例数数据。季度报告中的数据仅限于按辖区和血清群(如果已知)描述侵袭性脑膜炎球菌病病例数,并在 2024 年扩展到包括头孢曲松、青霉素、环丙沙星和利福平的抗菌药耐药性数据。AMSP 年度报告中载有对每个日历年 IMD 实验室确诊情况的全面分析。
{"title":"Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2024.","authors":"Monica M Lahra, Sonya Natasha Hutabarat, Tiffany R Hogan","doi":"10.33321/cdi.2024.48.54","DOIUrl":"https://doi.org/10.33321/cdi.2024.48.54","url":null,"abstract":"<p><strong>Abstract: </strong>The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and molecular based techniques. Data contained in quarterly reports are restricted to a description of case numbers of IMD by jurisdiction and serogroup, where known and expanded in 2024 to include antimicrobial resistance data for ceftriaxone, penicillin, ciprofloxacin and rifampicin. A full analysis of laboratory confirmations of IMD in each calendar year is contained in the AMSP annual reports.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Never waste a measles outbreak. 切勿浪费麻疹疫情。
Q3 Medicine Pub Date : 2024-11-21 DOI: 10.33321/cdi.2024.48.62
David N Durrheim

Abstract: This editorial focuses on the instructive value of carefully investigated measles outbreaks with reference to the outbreak report, also published today in CDI (doi: /10.33321/cdi.2024.48.61), documenting an apparent measles secondary vaccine failure affecting a Sunshine Coast childcare facility with no ongoing transmission.

摘要:这篇社论的重点是仔细调查麻疹疫情的指导价值,并参考了今天也发表在《CDI》上的疫情报告(doi: /10.33321/cdi.2024.48.61),该报告记录了阳光海岸一家托儿所的麻疹二联疫苗明显失效,但没有持续传播。
{"title":"Never waste a measles outbreak.","authors":"David N Durrheim","doi":"10.33321/cdi.2024.48.62","DOIUrl":"https://doi.org/10.33321/cdi.2024.48.62","url":null,"abstract":"<p><strong>Abstract: </strong>This editorial focuses on the instructive value of carefully investigated measles outbreaks with reference to the outbreak report, also published today in CDI (doi: /10.33321/cdi.2024.48.61), documenting an apparent measles secondary vaccine failure affecting a Sunshine Coast childcare facility with no ongoing transmission.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2024. 澳大利亚脑膜炎球菌监测:报告期为 2024 年 1 月 1 日至 3 月 31 日。
Q3 Medicine Pub Date : 2024-11-21 DOI: 10.33321/cdi.2024.48.53
Monica M Lahra, Sonya Natasha Hutabarat, Tiffany R Hogan

Abstract: The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and molecular based techniques. Data contained in quarterly reports are restricted to a description of case numbers of IMD by jurisdiction and serogroup, where known and expanded in 2024 to include antimicrobial resistance data for ceftriaxone, penicillin, ciprofloxacin and rifampicin. A full analysis of laboratory confirmations of IMD in each calendar year is contained in the AMSP annual reports.

摘要:澳大利亚脑膜炎球菌监测计划(AMSP)的参考实验室利用培养和分子技术报告经实验室检测确诊的侵袭性脑膜炎球菌病(IMD)病例数数据。季度报告中的数据仅限于按辖区和血清群(如果已知)描述侵袭性脑膜炎球菌病病例数,并在 2024 年扩展到包括头孢曲松、青霉素、环丙沙星和利福平的抗菌药耐药性数据。AMSP 年度报告中载有对每个日历年 IMD 实验室确诊情况的全面分析。
{"title":"Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2024.","authors":"Monica M Lahra, Sonya Natasha Hutabarat, Tiffany R Hogan","doi":"10.33321/cdi.2024.48.53","DOIUrl":"https://doi.org/10.33321/cdi.2024.48.53","url":null,"abstract":"<p><strong>Abstract: </strong>The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and molecular based techniques. Data contained in quarterly reports are restricted to a description of case numbers of IMD by jurisdiction and serogroup, where known and expanded in 2024 to include antimicrobial resistance data for ceftriaxone, penicillin, ciprofloxacin and rifampicin. A full analysis of laboratory confirmations of IMD in each calendar year is contained in the AMSP annual reports.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fresh produce-associated foodborne disease outbreaks in Australia, 2001 to 2017. 2001年至2017年澳大利亚与新鲜农产品相关的食源性疾病暴发。
Q3 Medicine Pub Date : 2024-10-23 DOI: 10.33321/cdi.2024.48.19
Joanna G Rothwell, Rhiannon Wallace, Mark Bradbury, Laura Ford, Kathryn Glass, Robyn McConchie, Dee Carter, Martyn D Kirk

Abstract: Fresh produce is an important source of foodborne outbreaks in Australia. Using descriptive analysis, we examined confirmed and suspected foodborne outbreaks associated with fresh produce in Australia recorded in the OzFoodNet outbreak register from 2001 to 2017. The outbreak register contains reports of foodborne disease outbreaks collected by OzFoodNet epidemiologists and public health officials. A fresh produce outbreak was defined as the occurrence of two or more cases of the same illness in which the investigation had implicated a common food and this food contained fresh produce. A total of 92 fresh produce outbreaks were reported, encompassing 3,422 reported illnesses, 446 hospitalisations and four deaths. Of these outbreaks, 76.1% (70/92) were caused by a known pathogen, with the majority caused by either Salmonella enterica (n = 30) or Norovirus (n = 29). Most outbreaks (77.2%; 71/92) were associated with consumption of foods containing multiple ingredients, some of which were not fresh produce. The largest outbreaks associated with a single fresh produce item included bean sprouts contaminated with S. enterica serovar Saintpaul (419 illnesses and 76 hospitalisations) and semi-dried tomatoes contaminated with Hepatitis A (372 illnesses and 169 hospitalisations). Restaurants (45.7%; n = 42/92) and commercial catering (15.2%: n = 14/92) were common settings for fresh produce outbreaks. Outbreaks occurred in all states and territories of Australia and in all seasons, with an increased frequency in the warmer months (September-May). Although the number of fresh produce-associated outbreaks did not seem to be increasing in Australia, integrated surveillance is needed to rapidly identify sources of infection due to the propensity of these outbreaks to be large and widespread.

摘要:新鲜农产品是澳大利亚食源性疾病暴发的一个重要来源。通过描述性分析,我们研究了2001年至2017年OzFoodNet疫情登记册中记录的与澳大利亚新鲜农产品相关的确诊和疑似食源性疫情。疫情登记簿包含由 OzFoodNet 流行病学家和公共卫生官员收集的食源性疾病疫情报告。鲜活农产品疫情的定义是,发生两例或两例以上相同疾病的病例,且调查牵涉到一种常见食物,而这种食物中含有鲜活农产品。共报告了 92 起鲜活农产品疫情,涉及 3422 例报告病例、446 例住院病例和 4 例死亡病例。在这些暴发事件中,76.1%(70/92)是由已知病原体引起的,其中大多数是由肠炎沙门氏菌(30 例)或诺如病毒(29 例)引起的。大多数疫情(77.2%;71/92)与食用含有多种配料的食品有关,其中一些并非新鲜农产品。与单一新鲜农产品有关的最大疫情包括受圣帕氏杆菌污染的豆芽(419 例疾病和 76 例住院治疗)和受甲型肝炎污染的半干番茄(372 例疾病和 169 例住院治疗)。餐馆(45.7%;n = 42/92)和商业餐饮业(15.2%:n = 14/92)是新鲜农产品爆发的常见场所。疫情爆发发生在澳大利亚的所有州和地区以及所有季节,在温暖的月份(9 月至 5 月)爆发的频率更高。尽管澳大利亚与新鲜农产品相关的疫情爆发数量似乎没有增加,但由于这些疫情爆发的规模大、范围广,因此需要进行综合监测,以迅速确定感染源。
{"title":"Fresh produce-associated foodborne disease outbreaks in Australia, 2001 to 2017.","authors":"Joanna G Rothwell, Rhiannon Wallace, Mark Bradbury, Laura Ford, Kathryn Glass, Robyn McConchie, Dee Carter, Martyn D Kirk","doi":"10.33321/cdi.2024.48.19","DOIUrl":"https://doi.org/10.33321/cdi.2024.48.19","url":null,"abstract":"<p><strong>Abstract: </strong>Fresh produce is an important source of foodborne outbreaks in Australia. Using descriptive analysis, we examined confirmed and suspected foodborne outbreaks associated with fresh produce in Australia recorded in the OzFoodNet outbreak register from 2001 to 2017. The outbreak register contains reports of foodborne disease outbreaks collected by OzFoodNet epidemiologists and public health officials. A fresh produce outbreak was defined as the occurrence of two or more cases of the same illness in which the investigation had implicated a common food and this food contained fresh produce. A total of 92 fresh produce outbreaks were reported, encompassing 3,422 reported illnesses, 446 hospitalisations and four deaths. Of these outbreaks, 76.1% (70/92) were caused by a known pathogen, with the majority caused by either Salmonella enterica (n = 30) or Norovirus (n = 29). Most outbreaks (77.2%; 71/92) were associated with consumption of foods containing multiple ingredients, some of which were not fresh produce. The largest outbreaks associated with a single fresh produce item included bean sprouts contaminated with S. enterica serovar Saintpaul (419 illnesses and 76 hospitalisations) and semi-dried tomatoes contaminated with Hepatitis A (372 illnesses and 169 hospitalisations). Restaurants (45.7%; n = 42/92) and commercial catering (15.2%: n = 14/92) were common settings for fresh produce outbreaks. Outbreaks occurred in all states and territories of Australia and in all seasons, with an increased frequency in the warmer months (September-May). Although the number of fresh produce-associated outbreaks did not seem to be increasing in Australia, integrated surveillance is needed to rapidly identify sources of infection due to the propensity of these outbreaks to be large and widespread.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gonococcal infections and risk factors for reinfection: a descriptive and case-case analysis of notifications in the Australian Capital Territory, 2017-2022. 淋球菌感染和再感染的风险因素:2017-2022年澳大利亚首都地区通报的描述性和病例分析。
Q3 Medicine Pub Date : 2024-10-23 DOI: 10.33321/cdi.2024.48.51
Jill Padrotta, Alexandra Marmor, Nevada Pingault, Davoud Pourmarzi

Background: In Australia, gonococcal infection notification rates are increasing with reinfections representing a substantial proportion of infections. Understanding the local epidemiology of gonococcal infections and reinfections and the risk factors for reinfection can assist with the design of targeted interventions. This study aimed to describe the epidemiology of gonococcal infections and reinfections between 2017 and 2022 in the Australian Capital Territory (ACT), and to examine the risk factors for reinfection.

Methods: Data for gonococcal infections notified in the ACT between 2017 and 2022 were described. The epidemiological characteristics of individuals with a single infection and reinfection were compared using a case-case study design.

Results: There were 1,886 gonococcal infection notifications during the study period. Of these, 20.4% were reinfections (n = 385). Of 1,501 individuals, 1,254 (83.5%) had a single infection and 247 (16.5%) had a reinfection. Between 2017 and 2022, the annual gonococcal infection notification rate per 100,000 population increased from 59.98 to 80.14 and the proportion of reinfections from 4.0% to 26.8%. Compared with those with a single infection, individuals with a reinfection had significantly greater odds of being male, of having a same-sex sexual exposure, of using HIV pre-exposure prophylaxis at diagnosis, and of having been diagnosed at a sexual health/family planning clinic. Individuals with a reinfection had significantly greater odds of being in the 25-34, 35-44 and 45-54 years age groups than in the 14-24 years age group. The odds of anatomical site of first infection being only the rectum, only the throat, or at more than one site, compared with urogenital only, were significantly greater for those with a reinfection.

Conclusion: Gonococcal reinfections contribute substantially to gonococcal infection notifications in the ACT. Targeted interventions are needed to prevent gonococcal reinfections among at-risk groups, particularly among men who have sex with men, people who use HIV pre-exposure prophylaxis, and individuals accessing sexual health/family planning services.

背景:在澳大利亚,淋球菌感染的通报率正在上升,其中再感染占了相当大的比例。了解当地淋球菌感染和再感染的流行病学以及再感染的风险因素有助于设计有针对性的干预措施。本研究旨在描述2017年至2022年期间澳大利亚首都地区(ACT)淋球菌感染和再感染的流行病学情况,并研究再感染的风险因素:研究描述了2017年至2022年间澳大利亚首都地区通报的淋球菌感染数据。采用病例研究设计,比较了单次感染者和再次感染者的流行病学特征:研究期间共通报了1886例淋球菌感染病例。其中,20.4%为再次感染(n = 385)。在 1501 人中,1254 人(83.5%)为单次感染,247 人(16.5%)为再次感染。2017 年至 2022 年期间,每 10 万人的淋球菌感染年通报率从 59.98 上升至 80.14,再感染比例从 4.0% 上升至 26.8%。与单次感染者相比,再次感染者中男性、有同性性接触、在诊断时使用过艾滋病暴露前预防措施以及在性健康/计划生育诊所确诊的几率明显更高。与 14-24 岁年龄组相比,25-34、35-44 和 45-54 岁年龄组再次感染的几率要大得多。再感染者的初次感染解剖部位仅为直肠、咽喉或一个以上部位的几率明显高于仅泌尿生殖器感染者:结论:淋球菌再感染在 ACT 淋球菌感染通报中占很大比例。需要采取有针对性的干预措施来预防高危人群中的淋球菌再感染,尤其是男男性行为者、使用艾滋病暴露前预防措施的人群以及接受性健康/计划生育服务的人群。
{"title":"Gonococcal infections and risk factors for reinfection: a descriptive and case-case analysis of notifications in the Australian Capital Territory, 2017-2022.","authors":"Jill Padrotta, Alexandra Marmor, Nevada Pingault, Davoud Pourmarzi","doi":"10.33321/cdi.2024.48.51","DOIUrl":"https://doi.org/10.33321/cdi.2024.48.51","url":null,"abstract":"<p><strong>Background: </strong>In Australia, gonococcal infection notification rates are increasing with reinfections representing a substantial proportion of infections. Understanding the local epidemiology of gonococcal infections and reinfections and the risk factors for reinfection can assist with the design of targeted interventions. This study aimed to describe the epidemiology of gonococcal infections and reinfections between 2017 and 2022 in the Australian Capital Territory (ACT), and to examine the risk factors for reinfection.</p><p><strong>Methods: </strong>Data for gonococcal infections notified in the ACT between 2017 and 2022 were described. The epidemiological characteristics of individuals with a single infection and reinfection were compared using a case-case study design.</p><p><strong>Results: </strong>There were 1,886 gonococcal infection notifications during the study period. Of these, 20.4% were reinfections (n = 385). Of 1,501 individuals, 1,254 (83.5%) had a single infection and 247 (16.5%) had a reinfection. Between 2017 and 2022, the annual gonococcal infection notification rate per 100,000 population increased from 59.98 to 80.14 and the proportion of reinfections from 4.0% to 26.8%. Compared with those with a single infection, individuals with a reinfection had significantly greater odds of being male, of having a same-sex sexual exposure, of using HIV pre-exposure prophylaxis at diagnosis, and of having been diagnosed at a sexual health/family planning clinic. Individuals with a reinfection had significantly greater odds of being in the 25-34, 35-44 and 45-54 years age groups than in the 14-24 years age group. The odds of anatomical site of first infection being only the rectum, only the throat, or at more than one site, compared with urogenital only, were significantly greater for those with a reinfection.</p><p><strong>Conclusion: </strong>Gonococcal reinfections contribute substantially to gonococcal infection notifications in the ACT. Targeted interventions are needed to prevent gonococcal reinfections among at-risk groups, particularly among men who have sex with men, people who use HIV pre-exposure prophylaxis, and individuals accessing sexual health/family planning services.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An outbreak of double carbapenemase-producing Klebsiella pneumoniae, harbouring NDM-5 and OXA-48 genes, at a tertiary hospital in Canberra, Australia. 澳大利亚堪培拉一家三级医院爆发了携带 NDM-5 和 OXA-48 基因的产碳青霉烯酶双重肺炎克雷伯氏菌疫情。
Q3 Medicine Pub Date : 2024-10-23 DOI: 10.33321/cdi.2024.48.50
Malizgani Mhango, Frances Sheehan, Callum Thirkell, Karina Kennedy

Abstract: In July 2023, a carbapenemase-producing Klebsiella pneumoniae (CPKP) with New Delhi metallo-beta-lactamase (NDM-5) and oxacillinase (OXA-48) carbapenemase genes was detected in the urine sample of a patient. A similar CPKP organism had previously been isolated from a surveillance rectal swab of an admitted patient, prompting an outbreak investigation. A confirmed case was defined as any suspected case in which a species of Enterobacterales was isolated from a clinical or surveillance specimen (infection or colonisation) exhibiting an NDM-5 or OXA-48 CPE gene or both, irrespective of phenotypic susceptibility. A descriptive epidemiological investigation was conducted to describe the investigation, infection prevention and control responses, and public health intervention carried out. Three confirmed cases of CPKP were identified, including the index case; 62 contacts were identified, of which 13 contacts were screened. CPKP transmission occurred between two patients on contact transmission-based precautions in separate single ensuite rooms. Despite being in the same ward, the patients did not share medical teams but shared nursing teams and ancillary staff. This study emphasises the importance of strict adherence to infection prevention and control practices and contact transmission-based precautions for patients admitted with carbapenemase-producing Enterobacterales.

摘要:2023年7月,在一名患者的尿液样本中检测到一种产碳青霉烯酶的肺炎克雷伯氏菌(CPKP),该菌带有新德里金属-β-内酰胺酶(NDM-5)和氧西林酶(OXA-48)碳青霉烯酶基因。此前,曾从一名入院患者的直肠拭子监测样本中分离出一种类似的 CPKP 微生物,从而引发了疫情调查。确诊病例是指从临床样本或监测样本(感染或定植)中分离出一种肠杆菌属病菌的疑似病例,该病菌带有 NDM-5 或 OXA-48 CPE 基因,或同时带有这两种基因,而不考虑表型易感性。我们开展了一项描述性流行病学调查,以描述所开展的调查、感染预防和控制对策以及公共卫生干预措施。共发现 3 例 CPKP 确诊病例,其中包括该病例;发现 62 名接触者,并对其中 13 名接触者进行了筛查。CPKP 的传播发生在两个病人之间,他们分别住在不同的单人套间病房,并采取了基于接触传播的预防措施。尽管住在同一病房,但这两名患者没有共用医疗团队,而是共用护理团队和辅助人员。本研究强调了严格遵守感染预防与控制规范和接触传播预防措施对于收治产碳青霉烯酶肠杆菌患者的重要性。
{"title":"An outbreak of double carbapenemase-producing Klebsiella pneumoniae, harbouring NDM-5 and OXA-48 genes, at a tertiary hospital in Canberra, Australia.","authors":"Malizgani Mhango, Frances Sheehan, Callum Thirkell, Karina Kennedy","doi":"10.33321/cdi.2024.48.50","DOIUrl":"https://doi.org/10.33321/cdi.2024.48.50","url":null,"abstract":"<p><strong>Abstract: </strong>In July 2023, a carbapenemase-producing <i>Klebsiella pneumoniae</i> (CPKP) with New Delhi metallo-beta-lactamase (NDM-5) and oxacillinase (OXA-48) carbapenemase genes was detected in the urine sample of a patient. A similar CPKP organism had previously been isolated from a surveillance rectal swab of an admitted patient, prompting an outbreak investigation. A confirmed case was defined as any suspected case in which a species of Enterobacterales was isolated from a clinical or surveillance specimen (infection or colonisation) exhibiting an NDM-5 or OXA-48 CPE gene or both, irrespective of phenotypic susceptibility. A descriptive epidemiological investigation was conducted to describe the investigation, infection prevention and control responses, and public health intervention carried out. Three confirmed cases of CPKP were identified, including the index case; 62 contacts were identified, of which 13 contacts were screened. CPKP transmission occurred between two patients on contact transmission-based precautions in separate single ensuite rooms. Despite being in the same ward, the patients did not share medical teams but shared nursing teams and ancillary staff. This study emphasises the importance of strict adherence to infection prevention and control practices and contact transmission-based precautions for patients admitted with carbapenemase-producing Enterobacterales.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learning from COVID-19: strengthening Australia's research capacity through preparedness and collaboration. 从 COVID-19 中学习:通过准备与合作加强澳大利亚的研究能力。
Q3 Medicine Pub Date : 2024-10-23 DOI: 10.33321/cdi.2024.48.58
Miranda Z Smith, Janelle Bowden, Linda Cristine, Anthony L Cunningham, John Kaldor, Sharon R Lewin, Andrew Singer, Robyn L Ward, Tania C Sorrell

Summary: The coronavirus disease 2019 (COVID-19) pandemic has highlighted that preparedness for and responsiveness to pandemics requires public health platforms and processes which are nimble and evidence-based and a research ecosystem which is rapidly responsive to the evolving needs of society and decision-makers. The national BEAT COVID-19 research consortium was funded in 2020 by the Snow Medical Research Foundation (Snow Medical). Its Expert Advisory Committee met with the consortium post-pandemic to summarise the research undertaken and to consider lessons learned through the research response to COVID-19 in Australia. The panel observed that philanthropy offered an important 'kick-starter' funding mechanism for urgent research, which facilitated leveraging of additional funds. It further agreed that research requirements for strengthening Australia's pandemic preparedness and response include: (1) development of a national health and medical research strategy for pandemic research; (2) long-term investment in pre-established research partnerships and networks; (3) systemic procedural improvements, e.g. in ethics, governance and resource allocation; (4) responsive funding mechanisms including philanthropy; and (5) integration of research outputs into health practice and decision-making, as illustrated in Figure 1.

摘要:2019 年冠状病毒病(COVID-19)大流行突显出,对大流行病的准备和响应需要灵活、以证据为基础的公共卫生平台和流程,以及一个能快速响应社会和决策者不断变化的需求的研究生态系统。2020 年,国家 BEAT COVID-19 研究联盟获得了斯诺医学研究基金会(斯诺医学基金会)的资助。其专家咨询委员会在疫情结束后与该联盟举行了会议,总结所开展的研究工作,并审议澳大利亚在研究应对 COVID-19 过程中汲取的经验教训。专家小组认为,慈善事业为紧急研究提供了一个重要的 "启动 "筹资机制,有利于利用额外资金。小组还一致认为,加强澳大利亚大流行病防备和应对的研究要求包括(1) 为大流行病研究制定国家卫生和医学研究战略;(2) 对预先建立的研究伙伴关系和网络进行长期投资;(3) 系统性程序改进,如伦理、治理和资源分配;(4) 包括慈善事业在内的响应性筹资机制;以及 (5) 将研究成果纳入卫生实践和决策,如图 1 所示。
{"title":"Learning from COVID-19: strengthening Australia's research capacity through preparedness and collaboration.","authors":"Miranda Z Smith, Janelle Bowden, Linda Cristine, Anthony L Cunningham, John Kaldor, Sharon R Lewin, Andrew Singer, Robyn L Ward, Tania C Sorrell","doi":"10.33321/cdi.2024.48.58","DOIUrl":"https://doi.org/10.33321/cdi.2024.48.58","url":null,"abstract":"<p><strong>Summary: </strong>The coronavirus disease 2019 (COVID-19) pandemic has highlighted that preparedness for and responsiveness to pandemics requires public health platforms and processes which are nimble and evidence-based and a research ecosystem which is rapidly responsive to the evolving needs of society and decision-makers. The national BEAT COVID-19 research consortium was funded in 2020 by the Snow Medical Research Foundation (Snow Medical). Its Expert Advisory Committee met with the consortium post-pandemic to summarise the research undertaken and to consider lessons learned through the research response to COVID-19 in Australia. The panel observed that philanthropy offered an important 'kick-starter' funding mechanism for urgent research, which facilitated leveraging of additional funds. It further agreed that research requirements for strengthening Australia's pandemic preparedness and response include: (1) development of a national health and medical research strategy for pandemic research; (2) long-term investment in pre-established research partnerships and networks; (3) systemic procedural improvements, e.g. in ethics, governance and resource allocation; (4) responsive funding mechanisms including philanthropy; and (5) integration of research outputs into health practice and decision-making, as illustrated in Figure 1.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New primary production and processing standards developed to reduce foodborne illness risks. 制定新的初级生产和加工标准,降低食源性疾病风险。
Q3 Medicine Pub Date : 2024-10-23 DOI: 10.33321/cdi.2024.48.60

Abstract: This editorial summarises a set of three new standards developed by Food Standards Australia New Zealand, which respectively address food safety requirements for the commodities of berries, leafy vegetables, and melons.

摘要:这篇社论概述了澳大利亚新西兰食品标准局制定的一套三项新标准,分别涉及浆果、叶菜和瓜类商品的食品安全要求。
{"title":"New primary production and processing standards developed to reduce foodborne illness risks.","authors":"","doi":"10.33321/cdi.2024.48.60","DOIUrl":"https://doi.org/10.33321/cdi.2024.48.60","url":null,"abstract":"<p><strong>Abstract: </strong>This editorial summarises a set of three new standards developed by Food Standards Australia New Zealand, which respectively address food safety requirements for the commodities of berries, leafy vegetables, and melons.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-led diphtheria vaccination campaign to manage a diphtheria outbreak in a remote Aboriginal community. 在偏远土著社区开展社区主导的白喉疫苗接种活动,以控制白喉疫情。
Q3 Medicine Pub Date : 2024-10-23 DOI: 10.33321/cdi.2024.48.49
Allison Hempenstall, Joanne Neville, Caroline Taunton, Valmay Fisher, Vince Connellan, Alice Tayley, Georgina Keys, Josh Hanson

Abstract: In 2022, five cases of diphtheria were identified in and around Wujal Wujal, a discrete Aboriginal community in Far North Queensland. This prompted a mass diphtheria vaccination campaign in the community which increased the proportion of residents aged ≥ 14 years receiving a diphtheria containing vaccine in the prior twelve months from 5% to 74%. No further cases were detected in the subsequent twenty-two months.

摘要:2022 年,昆士兰州远北地区的一个离散原住民社区 Wujal Wujal 及其周边地区发现了五例白喉病例。这促使该社区开展了大规模的白喉疫苗接种活动,使年龄≥ 14 岁的居民在之前 12 个月中接种白喉疫苗的比例从 5%增至 74%。在随后的 22 个月中,没有再发现病例。
{"title":"Community-led diphtheria vaccination campaign to manage a diphtheria outbreak in a remote Aboriginal community.","authors":"Allison Hempenstall, Joanne Neville, Caroline Taunton, Valmay Fisher, Vince Connellan, Alice Tayley, Georgina Keys, Josh Hanson","doi":"10.33321/cdi.2024.48.49","DOIUrl":"10.33321/cdi.2024.48.49","url":null,"abstract":"<p><strong>Abstract: </strong>In 2022, five cases of diphtheria were identified in and around Wujal Wujal, a discrete Aboriginal community in Far North Queensland. This prompted a mass diphtheria vaccination campaign in the community which increased the proportion of residents aged ≥ 14 years receiving a diphtheria containing vaccine in the prior twelve months from 5% to 74%. No further cases were detected in the subsequent twenty-two months.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"48 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Communicable diseases intelligence (2018)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1